Title	Publication Date	Language	Citations
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions	2020/09/01	English	206
The ecology of ticks and epidemiology of tick-borne viral diseases	2014/08/01	English	204
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer	2020/05/01	English	202
Treatment of Argentine hemorrhagic fever	2008/04/01	English	200
Current status and challenges of antiretroviral research and therapy	2010/01/01	English	198
Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle	2007/09/01	English	195
The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development	2015/06/01	English	193
Core protein: A pleiotropic keystone in the HBV lifecycle	2015/09/01	English	190
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes	2018/02/01	English	188
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities	2015/09/01	English	185
The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell	2005/06/01	English	185
The FDA-approved drug sofosbuvir inhibits Zika virus infection	2017/01/01	English	179
Molecular targets for flavivirus drug discovery	2009/01/01	English	177
In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination	2004/02/01	English	175
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication	2015/06/01	English	174
Extracts and molecules from medicinal plants against herpes simplex viruses	2005/08/01	English	173
Current and future antiviral therapy of severe seasonal and avian influenza	2008/04/01	English	169
Antiviral properties of hemocyanin isolated from shrimp Penaeus monodon	2004/02/01	English	168
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold	2019/02/01	English	167
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art	2009/05/01	English	167
Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy	1995/12/01	English	167
Vaccinia virus vaccines: Past, present and future	2009/10/01	English	166
Receptor recognition and cross-species infections of SARS coronavirus	2013/10/01	English	166
The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro	1992/06/01	English	165
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)	2008/03/01	English	164
Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210	2010/11/01	English	164
Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model	2014/04/01	English	163
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication	2008/01/01	English	163
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes	2007/03/01	English	163
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034	2006/06/01	English	162